Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution.
Cerebral vasospasm is the classic cause of delayed neurological deterioration after aneurysmal subarachnoid hemorrhage, leading to cerebral ischemia and infarction, and thus to poor outcome and occasionally death. Advances in diagnosis and treatment-principally the use of nimodipine, intensive care management, hemodynamic manipulations and endovascular neuroradiology procedures-have improved the prospects for these patients, but outcomes remain disappointing. Recent clinical trials have demonstrated marked prevention of vasospasm with the endothelin receptor antagonist clazosentan, yet patient outcome was not improved. This Review considers possible explanations for this result and proposes alternative causes of neurological deterioration and poor outcome after subarachnoid hemorrhage, including delayed effects of global cerebral ischemia, thromboembolism, microcirculatory dysfunction and cortical spreading depression.
Macdonald
R Loch
RL
Division of Neurosurgery at St Michael's Hospital, University of Toronto, Toronto, Canada. macdonaldlo@smh.toronto.on.ca
Pluta
Ryszard M
RM
Zhang
John H
JH
D000818:Animals; D002545:Brain Ischemia / Q000150:complications / Q000378:metabolism / Q000473:pathology; D006801:Humans; D013345:Subarachnoid Hemorrhage / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D020301:Vasospasm, Intracranial / Q000209:etiology / Q000378:metabolism* / Q000473:pathology